Follow the LSL Pharma Group Inc. stock price and the full insider trade history of the company, a listed equity based in Canada. Shares trade on the CA market, under the supervision of SEDI. Operating in the Health Care sector, LSL Pharma Group Inc. has published 10 reports. Market capitalisation: €47.5m. The latest transaction was disclosed on 6 July 2026 (50 - Grant of options). Among the most active insiders: Allard, Guy Paul. The full history is accessible without an account.
10
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
45Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,232 of 29,063 companies
12.0
score / 100
Value
12
Quality
12
FCF yld-18%
Earn yld-7.0%
EV/EBITDA34.5x
ROE-32%
Gross mgn18%
Net mgn-9.8%
Debt/EBITDA16.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.